Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes

ClinicalTrials.gov ID: NCT04560998

Public ClinicalTrials.gov record NCT04560998. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 11:57 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effects of Semaglutide on Functional Capacity in Patients With Type 2 Diabetes and Peripheral Arterial Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is done to see if semaglutide has an effect on walking ability compared with placebo (dummy medicine) in people with peripheral arterial disease (PAD) and type 2 diabetes. Participants will either get semaglutide or placebo ("dummy") medicine - which treatment participants get is decided by chance. Semaglutide is a medicine for type 2 diabetes that can be prescribed by doctors in some countries. Participants will get the study medicine (semaglutide or placebo) in a pre-filled pen for injection. Participants must inject it once a week into the stomach area, thigh, or upper arm, at any time of the day. The study will last for about 59 weeks. Participants will have 8 clinic visits and 1 phone call with the study doctor. At some clinic visits, participants will have blood tests. At some visits participants will also do a treadmill test to measure how far they can walk. Women cannot take part if pregnant, breast-feeding or planning to become pregnant during the study period.

Study identification

NCT ID
NCT04560998
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
792 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 1, 2020 (Actual)
Primary completion
Jun 5, 2024 (Actual)
Completion
Jul 12, 2024 (Actual)
Last update posted
Jun 5, 2026

2020 – 2024

United States locations

U.S. sites
88
U.S. states
29
U.S. cities
67
Facility City State ZIP Site status
Cardiology, PC Birmingham Alabama 35211 —
Cardiovascular Associates of the Southeast Birmingham Alabama 35243 —
Univ of Alabama Birmingham Birmingham Alabama 35294 —
Chandler Regional Medical Center Chandler Arizona 85224 —
Abrazo Diabetes Care Center Glendale Arizona 85308 —
Central Arkansas Veteran's Healthcare System Little Rock Arkansas 72205 —
Cardio Innovation & Resch Ctr Long Beach California 90813 —
Angel City Research, Inc. Los Angeles California 90010 —
St. Joseph Heritage Healthcare_Mission Viejo Mission Viejo California 92691 —
Adventist Hlth St Helena Hosp St. Helena California 94574 —
Stanford University Medical Center Stanford California 94305 —
Stanford University_Stanford Stanford California 94305 —
Rocky Mount Reg VA Med-DN Aurora Colorado 80045 —
UC Health Heart & Vascular Center Aurora Colorado 80045 —
Univ of Colorado at Denver Aurora Colorado 80045 —
Bay Area Cardiology Associates, P.A. Brandon Florida 33511 —
Clearwater Cardiovascular Consultants Clearwater Florida 33756 —
Tampa Bay Medical Research Clearwater Florida 33761 —
Jacksonville Ctr For Clin Res Jacksonville Florida 32216 —
CV Res Ctr of S Florida Miami Florida 33173 —
Cardiovascular Institute of Central Florida Ocala Florida 34471 —
DMI Research Pinellas Park Florida 33782 —
Cardiovascular Ctr of Sarasota Sarasota Florida 34239 —
University of South Florida Tampa Florida 33606 —
Piedmont Heart Institute Atlanta Georgia 30309 —
Accel Research Site-Georgia Eatonton Georgia 31024 —
Reg Infectious Dis Infuse Ctr La Grange Georgia 30240 —
Aiyan Diabetes Center Martinez Georgia 30907 —
Atlanta Heart Specialists, LLC Tucker Georgia 30084 —
Northwestern University_Chicago Chicago Illinois 60611 —
Endeavor Health Glenbook Hosp Glenview Illinois 60026 —
Central IL Diabetes and Clinical Research Springfield Illinois 62701 —
Cardiovascular Rsrch of NW_IN Munster Indiana 46321 —
Central Cardio Assoc HPS Elizabethtown Kentucky 42701 —
Cambridge Medical Trials Alexandria Louisiana 71301 —
LOUISIANA HEART Center Covington Louisiana 70433 —
Clinical Trials of Ame, LLC Monroe Louisiana 71201 —
Ascension Saint Agnes Heart Ca Baltimore Maryland 21229 —
Boston Medical Center_Boston_1 Boston Massachusetts 02118 —
Boston Medical Center_Cary Boston Massachusetts 02118 —
Steward St. Elizabeth's Medical Center Boston Massachusetts 02135 —
Minneapolis Cardiology Assoc Minneapolis Minnesota 55407-1195 —
University of Minnesota_Minneapolis_1 Minneapolis Minnesota 55455 —
Amicis Centers of Clinical Research St Louis Missouri 63128 —
Nebraska West Iowa Hlth System Omaha Nebraska 68105 —
Methodist Phys Clin Heart Cons Omaha Nebraska 68114 —
Dartmouth-Hitchcock Med Ctr Lebanon New Hampshire 03766 —
NJ Heart Linden New Jersey 07036 —
NYU Langone Med Assoc Chelsea New York New York 10001 —
Mount Sinai Hosp at NYC New York New York 10029 —
UNC- Chapel Hill Chapel Hill North Carolina 27599 —
NC Heart and Vascular Research Raleigh North Carolina 27607 —
Accellacare_NC Wilmington North Carolina 28401 —
Lillestol Research LLC Fargo North Dakota 58104 —
MetroHealth Medical Center Cleveland Ohio 44109 —
Mount Carmel Heart and Vascular Columbus Ohio 43213 —
Advanced Med Res Maumee Maumee Ohio 43537 —
South Oklahoma Heart Research, LLC Oklahoma City Oklahoma 73135 —
Capital Area Research LLC Camp Hill Pennsylvania 17011 —
Penn Presb Med Ctr Philadelphia Pennsylvania 19104 —
Thomas Jefferson Univ Di Rsrch Ctr Philadelphia Pennsylvania 19107 —
Temple University Hospital Philadelphia Pennsylvania 19140 —
Vanderbilt U Med Ctr_Nashville Nashville Tennessee 37232 —
PharmaTex Research Amarillo Texas 79106 —
St. David's Medical Center Austin Texas 78705 —
Soltero Cardiovascular Research Center Dallas Texas 75226 —
Velocity Clinical Res-Dallas Dallas Texas 75230 —
UT Southwestern Med Cntr Dallas Texas 75390-9302 —
UT Southwestern Dallas Texas 75390 —
Houston Methodist Hospital Houston Texas 77030-2703 —
Northwest Houston Cardiology, P.A. Houston Texas 77070 —
Houston Heart & Vascular Associates Humble Texas 77338 —
Texas Cardiology Associates of Houston Kingwood Texas 77339 —
Texas Tech University Health Science Center Lubbock Texas 79430-8183 —
North Dallas Research Associates McKinney Texas 75069 —
Clinical Trials of Texas, LLC San Antonio Texas 78229 —
Univ Of Texas Hlth Science Cntr San Antonio Texas 78229 —
UT Health San Antonio San Antonio Texas 78229 —
San Antonio Endovascular and Heart Institute San Antonio Texas 78258 —
Cardiovascular Associates East Texas Tyler Texas 75701 —
Victoria Heart and Vasc Ctr Victoria Texas 77901 —
Alpine Research Organization Inc Farmington Utah 84025 —
Inova Heart and Vascular Institute Falls Church Virginia 22042-3300 —
Carient Heart and Vascular Manassas Virginia 20109 —
Roanoke Heart Institute Roanoke Virginia 24014 —
Selma Medical Associates Winchester Virginia 22601-3834 —
Winchester Medical Center Winchester Virginia 22601 —
Aspirus Research Institute Wausau Wisconsin 54401 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 195 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04560998, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 5, 2026 · Synced Nov 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04560998 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →